CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation
Kyu Sang Lee, Gheeyoung Choe
JPTM. 2021;55(3):163-170.   Published online 2021 April 7    DOI: https://doi.org/10.4132/jptm.2021.02.22

Excel Download

Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation
Journal of Pathology and Translational Medicine. 2021;55(3):163-170   Crossref logo
Link1 Link2 Link3

Programmed death ligand‐1/programmed death‐1 inhibition therapy and programmed death ligand‐1 expression in urothelial bladder carcinoma
Chronic Diseases and Translational Medicine. 2019;5(3):170-177   Crossref logo
Link1 Link2 Link3 Link4 Link5

Editorial Comment to Programmed cell death‐ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma
International Journal of Urology. 2021;29(1):91-91   Crossref logo
Link1 Link2 Link3

Inter‐ and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma
Histopathology. 2019;76(2):191-200   Crossref logo
Link1 Link2 Link3 Link4

Lower neutrophil‐to‐lymphocyte ratio and positive programmed cell death ligand‐1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial carcinoma
Cancer Medicine. 2022;   Crossref logo
Link1 Link2 Link3

Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma
Diagnostic Pathology. 2019;14(1):   Crossref logo
Link1 Link2 Link3

Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations
Journal for ImmunoTherapy of Cancer. 2015;3(1):   Crossref logo
Link1 Link2 Link3 Link4

Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis
Frontiers in Oncology. 2021;10:   Crossref logo
Link1

Programmed cell death‐ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma
International Journal of Urology. 2021;29(1):89-90   Crossref logo
Link1 Link2 Link3

Safety and Activity of Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors for Platinum-Resistant Urothelial Cancer: A Meta-Analysis of Published Clinical Trials
Frontiers in Oncology. 2021;11:   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.